These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 27569987)
21. [Study of the effects of vinpocetin on cognitive functions]. Valikovics A; Csányi A; Németh L Ideggyogy Sz; 2012 Mar; 65(3-4):115-20. PubMed ID: 23136730 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of a research diagnostic algorithm for DSM-5 neurocognitive disorders in a population-based cohort of older adults. Eramudugolla R; Mortby ME; Sachdev P; Meslin C; Kumar R; Anstey KJ Alzheimers Res Ther; 2017 Mar; 9(1):15. PubMed ID: 28259179 [TBL] [Abstract][Full Text] [Related]
23. Donepezil and cognitive remediation therapy to augment treatment of alcohol use disorder related mild cognitive impairment (AUD-MCI): An open label pilot study with historical controls. Bell MD; Pittman B; Petrakis I; Yoon G Subst Abus; 2021; 42(4):412-416. PubMed ID: 33284058 [No Abstract] [Full Text] [Related]
24. Driving with Mild Cognitive Impairment or Dementia: Cognitive Test Performance and Proxy Report of Daily Life Function in Older Women. Vaughan L; Hogan PE; Rapp SR; Dugan E; Marottoli RA; Snively BM; Shumaker SA; Sink KM J Am Geriatr Soc; 2015 Sep; 63(9):1774-82. PubMed ID: 26338449 [TBL] [Abstract][Full Text] [Related]
25. [The activity of blood serum cholinesterases and neprilysin as potential biomarkers of mild-cognitive impairment and Alzheimer's disease]. Zhuravin IА; Nalivaeva NN; Kozlova DI; Kochkina EG; Fedorova YB; Gavrilova SI Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(12):110-117. PubMed ID: 26978503 [TBL] [Abstract][Full Text] [Related]
26. Cholinesterase inhibitors should not be prescribed for mild cognitive impairment. Russ TC Evid Based Med; 2014 Jun; 19(3):101. PubMed ID: 24482151 [No Abstract] [Full Text] [Related]
27. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia. Claxton A; Baker LD; Hanson A; Trittschuh EH; Cholerton B; Morgan A; Callaghan M; Arbuckle M; Behl C; Craft S J Alzheimers Dis; 2015; 44(3):897-906. PubMed ID: 25374101 [TBL] [Abstract][Full Text] [Related]
28. Impairment in instrumental activities of daily living with high cognitive demand is an early marker of mild cognitive impairment: the Sydney memory and ageing study. Reppermund S; Brodaty H; Crawford JD; Kochan NA; Draper B; Slavin MJ; Trollor JN; Sachdev PS Psychol Med; 2013 Nov; 43(11):2437-45. PubMed ID: 23308393 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of the Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training (USMART) program among patients with mild cognitive impairment: a randomized controlled crossover trial. Han JW; Son KL; Byun HJ; Ko JW; Kim K; Hong JW; Kim TH; Kim KW Alzheimers Res Ther; 2017 Jun; 9(1):39. PubMed ID: 28587629 [TBL] [Abstract][Full Text] [Related]
31. Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors. Erkinjuntti T; Román G; Gauthier S Neurol Res; 2004 Jul; 26(5):603-5. PubMed ID: 15265282 [TBL] [Abstract][Full Text] [Related]
32. Diagnostic utility of Montreal Cognitive Assessment in the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders: major and mild neurocognitive disorders. Liew TM; Feng L; Gao Q; Ng TP; Yap P J Am Med Dir Assoc; 2015 Feb; 16(2):144-8. PubMed ID: 25282632 [TBL] [Abstract][Full Text] [Related]
33. Effects of Ganglioside on Working Memory and the Default Mode Network in Individuals with Subjective Cognitive Impairment: A Randomized Controlled Trial. Jeon Y; Kim B; Kim JE; Kim BR; Ban S; Jeong JH; Kwon O; Rhie SJ; Ahn CW; Kim JH; Jung SU; Park SH; Lyoo IK; Yoon S Am J Chin Med; 2016; 44(3):489-514. PubMed ID: 27109158 [TBL] [Abstract][Full Text] [Related]
34. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease. Levey A; Lah J; Goldstein F; Steenland K; Bliwise D Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077 [TBL] [Abstract][Full Text] [Related]
36. Cognitive enhancers as a treatment for heroin relapse and addiction. Ma B; Mei D; Wang F; Liu Y; Zhou W Pharmacol Res; 2019 Mar; 141():378-383. PubMed ID: 30654135 [TBL] [Abstract][Full Text] [Related]
38. Donepezil Monotherapy for Neurocognitive Deficits and Psychobehavioral Disinhibition in an Adolescent Posttraumatic Brain Injury. Naguy A Am J Ther; 2018; 25(5):e593-e595. PubMed ID: 29901470 [No Abstract] [Full Text] [Related]
39. [Asthenia, mental fatigue and cognitive dysfunction]. Titova NV; Bezdolny YN; Katunina EA Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(5):38-47. PubMed ID: 37315240 [TBL] [Abstract][Full Text] [Related]
40. Effects of linalyl acetate on oxidative stress, inflammation and endothelial dysfunction: can linalyl acetate prevent mild cognitive impairment? Shin YK; Seol GH Front Pharmacol; 2023; 14():1233977. PubMed ID: 37576815 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]